News

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...
Raising serious regulatory concerns, the apex statutory body under the Central Drugs Standard Control Organisation (CDSCO), ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...
Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...
A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
Explore new strategies in cancer treatment. Discover how Justin Taylor's research offers hope for colorectal cancer therapies ...
An investigation has uncovered evidence of significant misreporting, raising new concerns about the approval and long-term ...